Global Human Low-Pass Whole Genome Sequencing Market Growth (Status and Outlook) 2026-2032
The global Human Low-Pass Whole Genome Sequencing market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Human low-pass whole-genome sequencing is generally defined as sequencing the genome. Combined with genotype imputation, it provides an alternative to genotyping arrays for trait mapping and polygenic score calculations.
United States market for Human Low-Pass Whole Genome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Low-Pass Whole Genome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Low-Pass Whole Genome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Low-Pass Whole Genome Sequencing players cover BGI, Breda Genetics, Azenta Life Sciences, Thermo Fisher Scientific, Psomagen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Human Low-Pass Whole Genome Sequencing Industry Forecast” looks at past sales and reviews total world Human Low-Pass Whole Genome Sequencing sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Low-Pass Whole Genome Sequencing sales for 2026 through 2032. With Human Low-Pass Whole Genome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Low-Pass Whole Genome Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Human Low-Pass Whole Genome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Low-Pass Whole Genome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Low-Pass Whole Genome Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Low-Pass Whole Genome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Low-Pass Whole Genome Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Low-Pass Whole Genome Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Human low-pass whole-genome sequencing is generally defined as sequencing the genome. Combined with genotype imputation, it provides an alternative to genotyping arrays for trait mapping and polygenic score calculations.
United States market for Human Low-Pass Whole Genome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Low-Pass Whole Genome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Low-Pass Whole Genome Sequencing is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Low-Pass Whole Genome Sequencing players cover BGI, Breda Genetics, Azenta Life Sciences, Thermo Fisher Scientific, Psomagen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Human Low-Pass Whole Genome Sequencing Industry Forecast” looks at past sales and reviews total world Human Low-Pass Whole Genome Sequencing sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Low-Pass Whole Genome Sequencing sales for 2026 through 2032. With Human Low-Pass Whole Genome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Low-Pass Whole Genome Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Human Low-Pass Whole Genome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Low-Pass Whole Genome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Low-Pass Whole Genome Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Low-Pass Whole Genome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Low-Pass Whole Genome Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Low-Pass Whole Genome Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
- Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
- Medical
- Scientific Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BGI
- Breda Genetics
- Azenta Life Sciences
- Thermo Fisher Scientific
- Psomagen
- Healgen Scientific
- Agilent Technologies
- Macrogen
- Veritas Genetics
- Centogene
- Nebula Genomics
- CD Genomics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Low-Pass Whole Genome Sequencing Market Size (2021-2032)
2.1.2 Human Low-Pass Whole Genome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Human Low-Pass Whole Genome Sequencing by Country/Region (2021, 2025 & 2032)
2.2 Human Low-Pass Whole Genome Sequencing Segment by Type
2.2.1 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
2.2.2 Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
2.2.3 Human Low-Pass Whole Genome Sequencing Market Size by Type
2.2.3.1 Human Low-Pass Whole Genome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
2.3 Human Low-Pass Whole Genome Sequencing Segment by Application
2.3.1 Medical
2.3.2 Scientific Research
2.3.3 Others
2.3.4 Human Low-Pass Whole Genome Sequencing Market Size by Application
2.3.4.1 Human Low-Pass Whole Genome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
3 HUMAN LOW-PASS WHOLE GENOME SEQUENCING MARKET SIZE BY PLAYER
3.1 Human Low-Pass Whole Genome Sequencing Market Size Market Share by Player
3.1.1 Global Human Low-Pass Whole Genome Sequencing Revenue by Player (2021-2026)
3.1.2 Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Player (2021-2026)
3.2 Global Human Low-Pass Whole Genome Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN LOW-PASS WHOLE GENOME SEQUENCING BY REGION
4.1 Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026)
4.2 Global Human Low-Pass Whole Genome Sequencing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Low-Pass Whole Genome Sequencing Market Size Growth (2021-2026)
4.4 APAC Human Low-Pass Whole Genome Sequencing Market Size Growth (2021-2026)
4.5 Europe Human Low-Pass Whole Genome Sequencing Market Size Growth (2021-2026)
4.6 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Human Low-Pass Whole Genome Sequencing Market Size by Country (2021-2026)
5.2 Americas Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026)
5.3 Americas Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026)
6.2 APAC Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026)
6.3 APAC Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2021-2026)
7.2 Europe Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026)
7.3 Europe Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Low-Pass Whole Genome Sequencing by Region (2021-2026)
8.2 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026)
8.3 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN LOW-PASS WHOLE GENOME SEQUENCING MARKET FORECAST
10.1 Global Human Low-Pass Whole Genome Sequencing Forecast by Region (2027-2032)
10.1.1 Global Human Low-Pass Whole Genome Sequencing Forecast by Region (2027-2032)
10.1.2 Americas Human Low-Pass Whole Genome Sequencing Forecast
10.1.3 APAC Human Low-Pass Whole Genome Sequencing Forecast
10.1.4 Europe Human Low-Pass Whole Genome Sequencing Forecast
10.1.5 Middle East & Africa Human Low-Pass Whole Genome Sequencing Forecast
10.2 Americas Human Low-Pass Whole Genome Sequencing Forecast by Country (2027-2032)
10.2.1 United States Market Human Low-Pass Whole Genome Sequencing Forecast
10.2.2 Canada Market Human Low-Pass Whole Genome Sequencing Forecast
10.2.3 Mexico Market Human Low-Pass Whole Genome Sequencing Forecast
10.2.4 Brazil Market Human Low-Pass Whole Genome Sequencing Forecast
10.3 APAC Human Low-Pass Whole Genome Sequencing Forecast by Region (2027-2032)
10.3.1 China Human Low-Pass Whole Genome Sequencing Market Forecast
10.3.2 Japan Market Human Low-Pass Whole Genome Sequencing Forecast
10.3.3 Korea Market Human Low-Pass Whole Genome Sequencing Forecast
10.3.4 Southeast Asia Market Human Low-Pass Whole Genome Sequencing Forecast
10.3.5 India Market Human Low-Pass Whole Genome Sequencing Forecast
10.3.6 Australia Market Human Low-Pass Whole Genome Sequencing Forecast
10.4 Europe Human Low-Pass Whole Genome Sequencing Forecast by Country (2027-2032)
10.4.1 Germany Market Human Low-Pass Whole Genome Sequencing Forecast
10.4.2 France Market Human Low-Pass Whole Genome Sequencing Forecast
10.4.3 UK Market Human Low-Pass Whole Genome Sequencing Forecast
10.4.4 Italy Market Human Low-Pass Whole Genome Sequencing Forecast
10.4.5 Russia Market Human Low-Pass Whole Genome Sequencing Forecast
10.5 Middle East & Africa Human Low-Pass Whole Genome Sequencing Forecast by Region (2027-2032)
10.5.1 Egypt Market Human Low-Pass Whole Genome Sequencing Forecast
10.5.2 South Africa Market Human Low-Pass Whole Genome Sequencing Forecast
10.5.3 Israel Market Human Low-Pass Whole Genome Sequencing Forecast
10.5.4 Turkey Market Human Low-Pass Whole Genome Sequencing Forecast
10.6 Global Human Low-Pass Whole Genome Sequencing Forecast by Type (2027-2032)
10.7 Global Human Low-Pass Whole Genome Sequencing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Human Low-Pass Whole Genome Sequencing Forecast
11 KEY PLAYERS ANALYSIS
11.1 BGI
11.1.1 BGI Company Information
11.1.2 BGI Human Low-Pass Whole Genome Sequencing Product Offered
11.1.3 BGI Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BGI Main Business Overview
11.1.5 BGI Latest Developments
11.2 Breda Genetics
11.2.1 Breda Genetics Company Information
11.2.2 Breda Genetics Human Low-Pass Whole Genome Sequencing Product Offered
11.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Breda Genetics Main Business Overview
11.2.5 Breda Genetics Latest Developments
11.3 Azenta Life Sciences
11.3.1 Azenta Life Sciences Company Information
11.3.2 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product Offered
11.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Azenta Life Sciences Main Business Overview
11.3.5 Azenta Life Sciences Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product Offered
11.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Psomagen
11.5.1 Psomagen Company Information
11.5.2 Psomagen Human Low-Pass Whole Genome Sequencing Product Offered
11.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Psomagen Main Business Overview
11.5.5 Psomagen Latest Developments
11.6 Healgen Scientific
11.6.1 Healgen Scientific Company Information
11.6.2 Healgen Scientific Human Low-Pass Whole Genome Sequencing Product Offered
11.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Healgen Scientific Main Business Overview
11.6.5 Healgen Scientific Latest Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Information
11.7.2 Agilent Technologies Human Low-Pass Whole Genome Sequencing Product Offered
11.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Agilent Technologies Main Business Overview
11.7.5 Agilent Technologies Latest Developments
11.8 Macrogen
11.8.1 Macrogen Company Information
11.8.2 Macrogen Human Low-Pass Whole Genome Sequencing Product Offered
11.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Macrogen Main Business Overview
11.8.5 Macrogen Latest Developments
11.9 Veritas Genetics
11.9.1 Veritas Genetics Company Information
11.9.2 Veritas Genetics Human Low-Pass Whole Genome Sequencing Product Offered
11.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Veritas Genetics Main Business Overview
11.9.5 Veritas Genetics Latest Developments
11.10 Centogene
11.10.1 Centogene Company Information
11.10.2 Centogene Human Low-Pass Whole Genome Sequencing Product Offered
11.10.3 Centogene Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Centogene Main Business Overview
11.10.5 Centogene Latest Developments
11.11 Nebula Genomics
11.11.1 Nebula Genomics Company Information
11.11.2 Nebula Genomics Human Low-Pass Whole Genome Sequencing Product Offered
11.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Nebula Genomics Main Business Overview
11.11.5 Nebula Genomics Latest Developments
11.12 CD Genomics
11.12.1 CD Genomics Company Information
11.12.2 CD Genomics Human Low-Pass Whole Genome Sequencing Product Offered
11.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 CD Genomics Main Business Overview
11.12.5 CD Genomics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Low-Pass Whole Genome Sequencing Market Size (2021-2032)
2.1.2 Human Low-Pass Whole Genome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Human Low-Pass Whole Genome Sequencing by Country/Region (2021, 2025 & 2032)
2.2 Human Low-Pass Whole Genome Sequencing Segment by Type
2.2.1 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
2.2.2 Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
2.2.3 Human Low-Pass Whole Genome Sequencing Market Size by Type
2.2.3.1 Human Low-Pass Whole Genome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
2.3 Human Low-Pass Whole Genome Sequencing Segment by Application
2.3.1 Medical
2.3.2 Scientific Research
2.3.3 Others
2.3.4 Human Low-Pass Whole Genome Sequencing Market Size by Application
2.3.4.1 Human Low-Pass Whole Genome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
3 HUMAN LOW-PASS WHOLE GENOME SEQUENCING MARKET SIZE BY PLAYER
3.1 Human Low-Pass Whole Genome Sequencing Market Size Market Share by Player
3.1.1 Global Human Low-Pass Whole Genome Sequencing Revenue by Player (2021-2026)
3.1.2 Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Player (2021-2026)
3.2 Global Human Low-Pass Whole Genome Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN LOW-PASS WHOLE GENOME SEQUENCING BY REGION
4.1 Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026)
4.2 Global Human Low-Pass Whole Genome Sequencing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Low-Pass Whole Genome Sequencing Market Size Growth (2021-2026)
4.4 APAC Human Low-Pass Whole Genome Sequencing Market Size Growth (2021-2026)
4.5 Europe Human Low-Pass Whole Genome Sequencing Market Size Growth (2021-2026)
4.6 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Human Low-Pass Whole Genome Sequencing Market Size by Country (2021-2026)
5.2 Americas Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026)
5.3 Americas Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026)
6.2 APAC Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026)
6.3 APAC Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2021-2026)
7.2 Europe Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026)
7.3 Europe Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Low-Pass Whole Genome Sequencing by Region (2021-2026)
8.2 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026)
8.3 Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN LOW-PASS WHOLE GENOME SEQUENCING MARKET FORECAST
10.1 Global Human Low-Pass Whole Genome Sequencing Forecast by Region (2027-2032)
10.1.1 Global Human Low-Pass Whole Genome Sequencing Forecast by Region (2027-2032)
10.1.2 Americas Human Low-Pass Whole Genome Sequencing Forecast
10.1.3 APAC Human Low-Pass Whole Genome Sequencing Forecast
10.1.4 Europe Human Low-Pass Whole Genome Sequencing Forecast
10.1.5 Middle East & Africa Human Low-Pass Whole Genome Sequencing Forecast
10.2 Americas Human Low-Pass Whole Genome Sequencing Forecast by Country (2027-2032)
10.2.1 United States Market Human Low-Pass Whole Genome Sequencing Forecast
10.2.2 Canada Market Human Low-Pass Whole Genome Sequencing Forecast
10.2.3 Mexico Market Human Low-Pass Whole Genome Sequencing Forecast
10.2.4 Brazil Market Human Low-Pass Whole Genome Sequencing Forecast
10.3 APAC Human Low-Pass Whole Genome Sequencing Forecast by Region (2027-2032)
10.3.1 China Human Low-Pass Whole Genome Sequencing Market Forecast
10.3.2 Japan Market Human Low-Pass Whole Genome Sequencing Forecast
10.3.3 Korea Market Human Low-Pass Whole Genome Sequencing Forecast
10.3.4 Southeast Asia Market Human Low-Pass Whole Genome Sequencing Forecast
10.3.5 India Market Human Low-Pass Whole Genome Sequencing Forecast
10.3.6 Australia Market Human Low-Pass Whole Genome Sequencing Forecast
10.4 Europe Human Low-Pass Whole Genome Sequencing Forecast by Country (2027-2032)
10.4.1 Germany Market Human Low-Pass Whole Genome Sequencing Forecast
10.4.2 France Market Human Low-Pass Whole Genome Sequencing Forecast
10.4.3 UK Market Human Low-Pass Whole Genome Sequencing Forecast
10.4.4 Italy Market Human Low-Pass Whole Genome Sequencing Forecast
10.4.5 Russia Market Human Low-Pass Whole Genome Sequencing Forecast
10.5 Middle East & Africa Human Low-Pass Whole Genome Sequencing Forecast by Region (2027-2032)
10.5.1 Egypt Market Human Low-Pass Whole Genome Sequencing Forecast
10.5.2 South Africa Market Human Low-Pass Whole Genome Sequencing Forecast
10.5.3 Israel Market Human Low-Pass Whole Genome Sequencing Forecast
10.5.4 Turkey Market Human Low-Pass Whole Genome Sequencing Forecast
10.6 Global Human Low-Pass Whole Genome Sequencing Forecast by Type (2027-2032)
10.7 Global Human Low-Pass Whole Genome Sequencing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Human Low-Pass Whole Genome Sequencing Forecast
11 KEY PLAYERS ANALYSIS
11.1 BGI
11.1.1 BGI Company Information
11.1.2 BGI Human Low-Pass Whole Genome Sequencing Product Offered
11.1.3 BGI Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BGI Main Business Overview
11.1.5 BGI Latest Developments
11.2 Breda Genetics
11.2.1 Breda Genetics Company Information
11.2.2 Breda Genetics Human Low-Pass Whole Genome Sequencing Product Offered
11.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Breda Genetics Main Business Overview
11.2.5 Breda Genetics Latest Developments
11.3 Azenta Life Sciences
11.3.1 Azenta Life Sciences Company Information
11.3.2 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product Offered
11.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Azenta Life Sciences Main Business Overview
11.3.5 Azenta Life Sciences Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product Offered
11.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Psomagen
11.5.1 Psomagen Company Information
11.5.2 Psomagen Human Low-Pass Whole Genome Sequencing Product Offered
11.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Psomagen Main Business Overview
11.5.5 Psomagen Latest Developments
11.6 Healgen Scientific
11.6.1 Healgen Scientific Company Information
11.6.2 Healgen Scientific Human Low-Pass Whole Genome Sequencing Product Offered
11.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Healgen Scientific Main Business Overview
11.6.5 Healgen Scientific Latest Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Information
11.7.2 Agilent Technologies Human Low-Pass Whole Genome Sequencing Product Offered
11.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Agilent Technologies Main Business Overview
11.7.5 Agilent Technologies Latest Developments
11.8 Macrogen
11.8.1 Macrogen Company Information
11.8.2 Macrogen Human Low-Pass Whole Genome Sequencing Product Offered
11.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Macrogen Main Business Overview
11.8.5 Macrogen Latest Developments
11.9 Veritas Genetics
11.9.1 Veritas Genetics Company Information
11.9.2 Veritas Genetics Human Low-Pass Whole Genome Sequencing Product Offered
11.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Veritas Genetics Main Business Overview
11.9.5 Veritas Genetics Latest Developments
11.10 Centogene
11.10.1 Centogene Company Information
11.10.2 Centogene Human Low-Pass Whole Genome Sequencing Product Offered
11.10.3 Centogene Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Centogene Main Business Overview
11.10.5 Centogene Latest Developments
11.11 Nebula Genomics
11.11.1 Nebula Genomics Company Information
11.11.2 Nebula Genomics Human Low-Pass Whole Genome Sequencing Product Offered
11.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Nebula Genomics Main Business Overview
11.11.5 Nebula Genomics Latest Developments
11.12 CD Genomics
11.12.1 CD Genomics Company Information
11.12.2 CD Genomics Human Low-Pass Whole Genome Sequencing Product Offered
11.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 CD Genomics Main Business Overview
11.12.5 CD Genomics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Low-Pass Whole Genome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Human Low-Pass Whole Genome Sequencing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Table 4. Major Players of Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
Table 5. Human Low-Pass Whole Genome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Table 8. Human Low-Pass Whole Genome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Table 11. Global Human Low-Pass Whole Genome Sequencing Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Player (2021-2026)
Table 13. Human Low-Pass Whole Genome Sequencing Key Players Head office and Products Offered
Table 14. Human Low-Pass Whole Genome Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region (2021-2026)
Table 19. Global Human Low-Pass Whole Genome Sequencing Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Human Low-Pass Whole Genome Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Human Low-Pass Whole Genome Sequencing Market Size Market Share by Country (2021-2026)
Table 23. Americas Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Table 25. Americas Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Table 27. APAC Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region (2021-2026)
Table 29. APAC Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Human Low-Pass Whole Genome Sequencing Market Size Market Share by Country (2021-2026)
Table 33. Europe Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Human Low-Pass Whole Genome Sequencing
Table 39. Key Market Challenges & Risks of Human Low-Pass Whole Genome Sequencing
Table 40. Key Industry Trends of Human Low-Pass Whole Genome Sequencing
Table 41. Global Human Low-Pass Whole Genome Sequencing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Human Low-Pass Whole Genome Sequencing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Human Low-Pass Whole Genome Sequencing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BGI Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 46. BGI Human Low-Pass Whole Genome Sequencing Product Offered
Table 47. BGI Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BGI Main Business
Table 49. BGI Latest Developments
Table 50. Breda Genetics Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 51. Breda Genetics Human Low-Pass Whole Genome Sequencing Product Offered
Table 52. Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Breda Genetics Main Business
Table 54. Breda Genetics Latest Developments
Table 55. Azenta Life Sciences Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 56. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product Offered
Table 57. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Azenta Life Sciences Main Business
Table 59. Azenta Life Sciences Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product Offered
Table 62. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. Psomagen Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 66. Psomagen Human Low-Pass Whole Genome Sequencing Product Offered
Table 67. Psomagen Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Psomagen Main Business
Table 69. Psomagen Latest Developments
Table 70. Healgen Scientific Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 71. Healgen Scientific Human Low-Pass Whole Genome Sequencing Product Offered
Table 72. Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Healgen Scientific Main Business
Table 74. Healgen Scientific Latest Developments
Table 75. Agilent Technologies Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 76. Agilent Technologies Human Low-Pass Whole Genome Sequencing Product Offered
Table 77. Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Agilent Technologies Main Business
Table 79. Agilent Technologies Latest Developments
Table 80. Macrogen Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 81. Macrogen Human Low-Pass Whole Genome Sequencing Product Offered
Table 82. Macrogen Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Macrogen Main Business
Table 84. Macrogen Latest Developments
Table 85. Veritas Genetics Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 86. Veritas Genetics Human Low-Pass Whole Genome Sequencing Product Offered
Table 87. Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Veritas Genetics Main Business
Table 89. Veritas Genetics Latest Developments
Table 90. Centogene Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 91. Centogene Human Low-Pass Whole Genome Sequencing Product Offered
Table 92. Centogene Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Centogene Main Business
Table 94. Centogene Latest Developments
Table 95. Nebula Genomics Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 96. Nebula Genomics Human Low-Pass Whole Genome Sequencing Product Offered
Table 97. Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Nebula Genomics Main Business
Table 99. Nebula Genomics Latest Developments
Table 100. CD Genomics Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 101. CD Genomics Human Low-Pass Whole Genome Sequencing Product Offered
Table 102. CD Genomics Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. CD Genomics Main Business
Table 104. CD Genomics Latest Developments
Table 1. Human Low-Pass Whole Genome Sequencing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Human Low-Pass Whole Genome Sequencing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Table 4. Major Players of Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
Table 5. Human Low-Pass Whole Genome Sequencing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Table 8. Human Low-Pass Whole Genome Sequencing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Table 11. Global Human Low-Pass Whole Genome Sequencing Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Player (2021-2026)
Table 13. Human Low-Pass Whole Genome Sequencing Key Players Head office and Products Offered
Table 14. Human Low-Pass Whole Genome Sequencing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region (2021-2026)
Table 19. Global Human Low-Pass Whole Genome Sequencing Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Human Low-Pass Whole Genome Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Human Low-Pass Whole Genome Sequencing Market Size Market Share by Country (2021-2026)
Table 23. Americas Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Table 25. Americas Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Table 27. APAC Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region (2021-2026)
Table 29. APAC Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Human Low-Pass Whole Genome Sequencing Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Human Low-Pass Whole Genome Sequencing Market Size Market Share by Country (2021-2026)
Table 33. Europe Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Human Low-Pass Whole Genome Sequencing
Table 39. Key Market Challenges & Risks of Human Low-Pass Whole Genome Sequencing
Table 40. Key Industry Trends of Human Low-Pass Whole Genome Sequencing
Table 41. Global Human Low-Pass Whole Genome Sequencing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Human Low-Pass Whole Genome Sequencing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Human Low-Pass Whole Genome Sequencing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. BGI Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 46. BGI Human Low-Pass Whole Genome Sequencing Product Offered
Table 47. BGI Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. BGI Main Business
Table 49. BGI Latest Developments
Table 50. Breda Genetics Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 51. Breda Genetics Human Low-Pass Whole Genome Sequencing Product Offered
Table 52. Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Breda Genetics Main Business
Table 54. Breda Genetics Latest Developments
Table 55. Azenta Life Sciences Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 56. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product Offered
Table 57. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Azenta Life Sciences Main Business
Table 59. Azenta Life Sciences Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product Offered
Table 62. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. Psomagen Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 66. Psomagen Human Low-Pass Whole Genome Sequencing Product Offered
Table 67. Psomagen Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Psomagen Main Business
Table 69. Psomagen Latest Developments
Table 70. Healgen Scientific Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 71. Healgen Scientific Human Low-Pass Whole Genome Sequencing Product Offered
Table 72. Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Healgen Scientific Main Business
Table 74. Healgen Scientific Latest Developments
Table 75. Agilent Technologies Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 76. Agilent Technologies Human Low-Pass Whole Genome Sequencing Product Offered
Table 77. Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Agilent Technologies Main Business
Table 79. Agilent Technologies Latest Developments
Table 80. Macrogen Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 81. Macrogen Human Low-Pass Whole Genome Sequencing Product Offered
Table 82. Macrogen Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Macrogen Main Business
Table 84. Macrogen Latest Developments
Table 85. Veritas Genetics Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 86. Veritas Genetics Human Low-Pass Whole Genome Sequencing Product Offered
Table 87. Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Veritas Genetics Main Business
Table 89. Veritas Genetics Latest Developments
Table 90. Centogene Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 91. Centogene Human Low-Pass Whole Genome Sequencing Product Offered
Table 92. Centogene Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Centogene Main Business
Table 94. Centogene Latest Developments
Table 95. Nebula Genomics Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 96. Nebula Genomics Human Low-Pass Whole Genome Sequencing Product Offered
Table 97. Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Nebula Genomics Main Business
Table 99. Nebula Genomics Latest Developments
Table 100. CD Genomics Details, Company Type, Human Low-Pass Whole Genome Sequencing Area Served and Its Competitors
Table 101. CD Genomics Human Low-Pass Whole Genome Sequencing Product Offered
Table 102. CD Genomics Human Low-Pass Whole Genome Sequencing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. CD Genomics Main Business
Table 104. CD Genomics Latest Developments
LIST OF FIGURES
Figure 1. Human Low-Pass Whole Genome Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Human Low-Pass Whole Genome Sequencing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Human Low-Pass Whole Genome Sequencing Sales Market Share by Country/Region (2025)
Figure 8. Human Low-Pass Whole Genome Sequencing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type in 2025
Figure 10. Human Low-Pass Whole Genome Sequencing in Medical
Figure 11. Global Human Low-Pass Whole Genome Sequencing Market: Medical (2021-2026) & ($ millions)
Figure 12. Human Low-Pass Whole Genome Sequencing in Scientific Research
Figure 13. Global Human Low-Pass Whole Genome Sequencing Market: Scientific Research (2021-2026) & ($ millions)
Figure 14. Human Low-Pass Whole Genome Sequencing in Others
Figure 15. Global Human Low-Pass Whole Genome Sequencing Market: Others (2021-2026) & ($ millions)
Figure 16. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application in 2025
Figure 17. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Player in 2025
Figure 18. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Human Low-Pass Whole Genome Sequencing Market Size 2021-2026 ($ millions)
Figure 20. APAC Human Low-Pass Whole Genome Sequencing Market Size 2021-2026 ($ millions)
Figure 21. Europe Human Low-Pass Whole Genome Sequencing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size 2021-2026 ($ millions)
Figure 23. Americas Human Low-Pass Whole Genome Sequencing Value Market Share by Country in 2025
Figure 24. United States Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region in 2025
Figure 29. APAC Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Figure 31. China Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Human Low-Pass Whole Genome Sequencing Market Size Market Share by Country in 2025
Figure 38. Europe Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 54. APAC Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 55. Europe Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 57. United States Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 58. Canada Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 61. China Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 62. Japan Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 63. Korea Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 65. India Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 66. Australia Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 67. Germany Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 68. France Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 69. UK Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 70. Italy Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 71. Russia Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 74. Israel Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 76. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 1. Human Low-Pass Whole Genome Sequencing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Low-Pass Whole Genome Sequencing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Human Low-Pass Whole Genome Sequencing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Human Low-Pass Whole Genome Sequencing Sales Market Share by Country/Region (2025)
Figure 8. Human Low-Pass Whole Genome Sequencing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type in 2025
Figure 10. Human Low-Pass Whole Genome Sequencing in Medical
Figure 11. Global Human Low-Pass Whole Genome Sequencing Market: Medical (2021-2026) & ($ millions)
Figure 12. Human Low-Pass Whole Genome Sequencing in Scientific Research
Figure 13. Global Human Low-Pass Whole Genome Sequencing Market: Scientific Research (2021-2026) & ($ millions)
Figure 14. Human Low-Pass Whole Genome Sequencing in Others
Figure 15. Global Human Low-Pass Whole Genome Sequencing Market: Others (2021-2026) & ($ millions)
Figure 16. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application in 2025
Figure 17. Global Human Low-Pass Whole Genome Sequencing Revenue Market Share by Player in 2025
Figure 18. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Human Low-Pass Whole Genome Sequencing Market Size 2021-2026 ($ millions)
Figure 20. APAC Human Low-Pass Whole Genome Sequencing Market Size 2021-2026 ($ millions)
Figure 21. Europe Human Low-Pass Whole Genome Sequencing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size 2021-2026 ($ millions)
Figure 23. Americas Human Low-Pass Whole Genome Sequencing Value Market Share by Country in 2025
Figure 24. United States Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region in 2025
Figure 29. APAC Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Figure 31. China Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Human Low-Pass Whole Genome Sequencing Market Size Market Share by Country in 2025
Figure 38. Europe Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Human Low-Pass Whole Genome Sequencing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 54. APAC Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 55. Europe Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 57. United States Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 58. Canada Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 61. China Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 62. Japan Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 63. Korea Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 65. India Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 66. Australia Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 67. Germany Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 68. France Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 69. UK Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 70. Italy Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 71. Russia Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 74. Israel Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
Figure 76. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Human Low-Pass Whole Genome Sequencing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Human Low-Pass Whole Genome Sequencing Market Size 2027-2032 ($ millions)
